Liping earned her PhD in 2022 under the supervision of Prof. Jennifer Stow at the University of Queensland. Her research focused on identifying molecular regulators in Toll-like receptor signalling pathways to facilitate selective inflammatory responses in innate immunity. Currently, as a postdoctoral research fellow in David Fairlie’s team, she is investigating the cellular uptake mechanisms of various cell-permeable compounds, including a novel anti-TB compound synthesized by the team. Her research has important implications for drug discovery and could pave the way for the development of more effective treatments